NCT05099250View on ClinicalTrials.gov

Adding Magnesium Sulfate to Bupivacaine in Ultrasound Guided Paravertebral Block for Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

September 10, 2020

Study Completion Date

February 15, 2021

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

Bupivacain

local anesthetic agent

DRUG

magnesium sulfate

In the central nervous system , it has depressant effects, by antagonism at NMDA receptors and through inhibition of release of catecholamines

OTHER

saline

medical solution

Trial Locations (1)

Unknown

Marwa Ibrahim Mohamed Abdo, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT05099250 - Adding Magnesium Sulfate to Bupivacaine in Ultrasound Guided Paravertebral Block for Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter